AssetMark’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
Other funds holding ABUS
AssetMark's ABUS Position: Q3 2026 in Review
AssetMark opened a new position in Arbutus Biopharma (ABUS) in Q3 2026: 17 shares worth $81. The stake represents ﹤0.01% of the portfolio and ranks #3697 among its holdings.
150 funds tracked by Wall St. Rank hold ABUS as of Q3 2026.
- AssetMark held 17 shares of Arbutus Biopharma worth $81 as of Q3 2026.
- Arbutus Biopharma was a new AssetMark position in Q3 2026.
- Arbutus Biopharma made up ﹤0.01% of AssetMark's portfolio in Q3 2026, its #3697 holding.
- 150 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q3 2026.
Based on AssetMark's 13F filing for Q3 2026, filed 21 Oct 2026.